This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
White patients were more likely to access a GLP-1 prescription than their Black and Hispanic counterparts, giving credence to fears of race-based health disparities with the blockbuster weight loss drug.
The data, published as a research note…